扩散性肺骨化及其与异常和二次形式的痕组织性肺炎的关联
Yasuhiro Terasaki1,2, Yasuhiko Nishioka3, Yusuke Kajimoto4
1Division of Pathology, Nippon Medical School Hospital, 1-1-5 Sendagi, Bunkyo-Ku, Tokyo, 113-8603, Japan. terasaki@nms.ac.jp.
Scientific reports
|April 11, 2025
概括
异形扩散性肺骨化 (I-DiPO) 涉及肺骨的形成. 研究表明,组织性肺炎 (CiOP) 病变是其独特病原发生的关键,提供了新的诊断见解.
科学领域:
- 肺病理学 肺病理学
- 组织病理学 组织病理学
- 宫外骨化发生在子宫外.
背景情况:
- 扩散性肺骨化 (DiPO) 具有广泛的肺骨形成的特点.
- 异形性DiPO (I-DiPO) 具有不清楚的骨化机制,具有诊断挑战.
- 创伤性组织性肺炎 (CiOP) 形成纤维结节,而不会损害肺部结构.
研究的目的:
- 研究I-DiPO的组织病理特征,专注于纤维化.
- 将I-DiPO与二次 DiPO (S-DiPO) 进行比较.
- 澄清DiPO.中的骨化机制.
主要方法:
- 对来自日本的全国DiPO调查数据的分析.
- 包括临床,放射学和病理学患者数据.
- 鉴定骨化模式和纤维化发现 (CiOP,OP,底纤维化).
主要成果:
- I-DiPO影响年轻患者,进展缓慢,死亡率低于S-DiPO.
- 在I-DiPO (61.1%) 和S-DiPO (71.4%) 中,CiOP病变与骨化病变密切相关.
- 组织性肺炎,CiOP和骨化病变在S-DiPO中经常同时发生.
结论:
- 迪波 (DiPO) 病变包括通过CiOP病变的骨化过渡.
- 结果提供了对DiPO诊断和管理的见解.
- 了解CiOP的作用对于DiPO研究至关重要.
相关概念视频
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
Pulmonary Tuberculosis II
201
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
201
Other Pulmonary Disorders
786
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
786
Pneumonia II: Pathophysiology
189
The pathophysiology of pneumonia involves the following steps:
189
Chronic Obstructive Pulmonary Disease-I: Introduction
2.7K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.7K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.6K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.6K


